Does INFLIXIMAB Cause Cutaneous vasculitis? 108 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Cutaneous vasculitis have been filed in association with INFLIXIMAB (Renflexis). This represents 0.1% of all adverse event reports for INFLIXIMAB.
108
Reports of Cutaneous vasculitis with INFLIXIMAB
0.1%
of all INFLIXIMAB reports
2
Deaths
23
Hospitalizations
How Dangerous Is Cutaneous vasculitis From INFLIXIMAB?
Of the 108 reports, 2 (1.9%) resulted in death, 23 (21.3%) required hospitalization, and 8 (7.4%) were considered life-threatening.
Is Cutaneous vasculitis Listed in the Official Label?
Yes, Cutaneous vasculitis is listed as a known adverse reaction in the official FDA drug label for INFLIXIMAB.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Cutaneous vasculitis?
METHOTREXATE (207)
ADALIMUMAB (193)
TOCILIZUMAB (161)
ETANERCEPT (148)
APIXABAN (131)
HYDROXYCHLOROQUINE (125)
LEFLUNOMIDE (116)
ABATACEPT (112)
ANAKINRA (112)
RITUXIMAB (93)
Which INFLIXIMAB Alternatives Have Lower Cutaneous vasculitis Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT